Roles
Research Associate Professor
-
Biography
Dr. Mittal earned his M.Sc. and Ph.D. in Microbiology from Panjab University, India, followed by postdoctoral training in infectious diseases and immunology. He later completed a Master’s degree in Clinical and Translational Science at the University of Miami. He currently holds the position of Research Assistant Professor at the University of Miami Miller School of Medicine and serves as Associate Director of Regulatory Affairs and Translational Research. His scientific contributions include over 130 peer-reviewed publications and multiple book chapters. Dr. Mittal has received multiple national and international awards and serves on various advisory, editorial, and grant review committees.
Dr. Mittal’s research focuses on uncovering the molecular mechanisms that drive the onset and progression of Type 1 diabetes, with the ultimate goal of developing effective therapeutic modalities. His work explores pathways involved in immune dysregulation, ß-cell stress, and inflammatory signaling, aiming to identify critical molecular targets that can be modulated to preserve islet function. By integrating translational immunology, disease modeling, and regulatory science, he seeks to bridge mechanistic insights with therapeutic innovation. His approach emphasizes translating preclinical findings from bench to bedside, including experience with FDA submissions, IRB protocols, and advancing therapies toward clinical application.
Dr. Mittal is driven by a deep commitment to accelerating cure-focused research that can transform the lives of individuals with Type 1 diabetes. His work is grounded in the belief that advancing scientific discovery must translate into real and lasting impact, restoring hope and health for patients and families affected by T1D. Outside of science, he enjoys exploring South Florida with his family, and supporting STEM outreach for underrepresented youth.
To elucidate the role of peroxynitrite signaling in ß-cell dysfunction in Type 1 diabetes and identify novel biomarkers and therapeutic targets. This project aims to pave the way for targeted interventions that preserve ß-cell function and delay disease progression using translational models and redox biology approaches. -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.